Treatment of cutaneous leishmaniasis with combination of allopurinol and low dose of meglumine antimoniate

Authors

  • A Momeni
  • M.R Raeiszadeh
  • M.S Amin-Javaheri
Abstract:

cutaneous leishmaniasis is one of the most prevalent endemic disease in Isfahan which is also hyperendemic in other parts of Iran.different treatment have been suddested for cutaneous Ieihmaniasis is glucantim and pentostam,however these drugs have significant side effects and can only be used intravenously.allopurinol is one of the oral medicines suggested for the treatment of cutaneous leishmaniasis.thegoal of this study  is to determined the healing effect of allopurinol with low doses of glucantim,on the treatment of cutaneous leishmaniasis ,and its comparison with the standard glucantim treatment regimen.in this open controlled study a total of 72 patients infected with cataneous leishmaniasis were divided randomly into two groups,the first group consists of 36 subjects which were treated for 20 days with intravenous glucantim(30mg/kg) and allopurinol tablets.the results were evaluated at the end of treatment period,one month and 3 months following the treatment.in the first group 74.2% and in the secind group 80.6% of the patients responded well to the treatment with no recurrence of the disease.no significant differnce was observed between two groups(p=0.408).significant side effect were not observed in either of the groups.therefore based on this results,it can be concluded that with simultaneous treatment of allopurinol and glucantim,one may reduce the number of injections and the side effects of the drugs.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study.

BACKGROUND Cutaneous leishmaniasis (CL) is an endemic disease in Iran, particularly in Kerman Province. Leishmaniasis recidivans (LR) is one of the characteristics of this disease with a chronic course. Most patients with LR are resistant to the usual treatments. METHODS Thirty-two patients (18 females and 14 males), suffering from LR, whose disease had been demonstrated by previous direct sm...

full text

omparative study of oral azithromycin and systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis

Background and aim: Complications and resistance to pentavalent antimonial agents in cutaneous leishmaniasis, exhibit the need for effective alternative drugs. The aim of this study was to compare the efficacy of oral azithromycin with systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis. Materials and Methods: Forty-seven patients with cutaneous leishmaniasis...

full text

Efficacy of topical 5% imiquimod with cryotherapy versus intralesional meglumine antimoniate in the treatment of anthroponotic cutaneous leishmaniasis

Background: Cutaneous leishmaniasis (CL) is a major world problem. Several types of treatment regimens have been suggested. Imiquimod demonstrated a leishmanicidal activity by increasing local cytokine production. The aim of this study was to determine the efficacy of topical 5% imiquimod with cryotherapy vs. intralesional meglumine antimoniate (MA) in treatment of anthroponotic (dry type) CL. ...

full text

Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis.

Treatment of cutaneous leishmaniasis is often difficult. Even though most cutaneous lesions will heal spontaneously, their duration cannot be predicted in an individual case. In general, only large, multiple or diffuse lesions of the face, head and neck need to be considered for therapeutic intervention. Pentavalent antimonials (sodium stibogluconate and meglumine antimoniate) administered intr...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 8  issue 3

pages  169- 174

publication date 2001-03-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023